Equities
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)36.23
  • Today's Change-0.38 / -1.04%
  • Shares traded6.65m
  • 1 Year change-44.13%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments7272,0691,758
Total Receivables, Net47330342
Total Inventory742523280
Prepaid expenses270199124
Other current assets, total1711895
Total current assets2,2293,2122,300
Property, plant & equipment, net3,0362,6631,737
Goodwill, net------
Intangibles, net1445652
Long term investments988112
Note receivable - long term------
Other long term assets143.6055
Total assets5,5286,0214,159
LIABILITIES
Accounts payable12510937
Accrued expenses22413887
Notes payable/short-term debt301122134
Current portion long-term debt/capital leases606052
Other current liabilities, total417448302
Total current liabilities1,128877612
Total long term debt91510550
Total debt1,277287237
Deferred income tax1.510.040.31
Minority interest------
Other liabilities, total465950
Total liabilities2,0911,041713
SHAREHOLDERS EQUITY
Common stock544544490
Additional paid-in capital6,2386,2333,743
Retained earnings (accumulated deficit)(2854)(1342)(343)
Treasury stock - common(440)(463)(449)
Unrealized gain (loss)(58)(1.22)0.31
Other equity, total6.879.105.58
Total equity3,4374,9803,446
Total liabilities & shareholders' equity5,5286,0214,159
Total common shares outstanding538539539
Treasury shares - common primary issue----0
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.